This site looks better in landscape mode

AKLRD develops novel solutions for inflammatory diseases with a high unmet need

AKLRD develops novel solutions for inflammatory diseases with a high unmet need

>300M

Worldwide more than 303 million people are affected by osteoarthritis

NEWS

EULAR & OARSI 2022 Presentations

Read More

NEWS

Senescence Research in APPA with INIBIC

Read More

NEWS

Completion of Phase 2a Human Trial

Read More

NEWS

 

EULAR & OARSI 2022 Presentations

Read More

 

Senescence Research in APPA with INIBIC

Read More

 

Completion of Phase 2a Human Trial

Read More